Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR) (Q84580238)
Jump to navigation
Jump to search
scientific article published on 15 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR) |
scientific article published on 15 July 2012 |
Statements
Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR) (English)
A Lanas
J L Goldstein
C M Wilcox
D A Peura
C Li
G H Sands